mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.04 |